Helport AI Opens Thailand Office 
playX Receives the ‘Enterprise Award’ at the Asia Golden Star Awards in Tokyo 
Zhibao Technology Announces Receipt of Nasdaq Deficiency Letter 
Fairfax County and Penzance Officials Break Ground on Next-Generation Digital Infrastructure Project to Power the World’s Deep Tech Future Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001
Saint-Herblain (France), December 2, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 2 December 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs…
Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pan-Biome Pharmaceuticals, Inc., a Vancouver based…
PHBI – Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pharmagreen Biotech, Inc., (OTC Pink: PHBI),…
Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference
DALLAS, Dec. 02, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories (OTC: RTSL) (“Rapid Therapeutic”…
Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC
Transaction provides Bespoke with a licensed marijuana infused production facility in Colorado. DENVER, Colorado., Dec….
Rubius Therapeutics Named to the List of Top Places to Work in Massachusetts by the Boston Globe and Top 3 Best Places to Work in Rhode Island by Providence Business News
Company Earns Spot on Both Lists for Second Year in a Row CAMBRIDGE, Mass., Dec….
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery
EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq:…
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Albireo Expands Leadership with Constantine Chinoporos as Chief Business Officer
– New chief business officer to oversee Company’s corporate and business development strategy – BOSTON,…
Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
78% of People Surveyed Want More Holistic Health Support This Season Manitoba Harvest. Manitoba Harvest….
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline readout of clinical…
Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine
Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against…
Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy
– DYNE-251, Dyne’s First DMD Program, is Being Developed for Patients with Mutations Amenable to…
Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan
NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline)Final FDA decision expected 2Â to…
SOTIO Secures €280m of Funding to Expand and Advance Clinical Pipeline
PPF Group provides funding to advance SOTIO through key clinical milestones Proceeds shall be used…
Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003
SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow
BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…